title: N-Acetylcysteine for Huntington's?
authors.affiliation: Deakin University, IMPACT Strategic Research Centre, School of Medicine, Faculty of Health, Geelong, VIC, Australia Orygen, The National Centre of Excellence in Youth Mental Health and the Centre for Youth Mental Health, The Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia mikebe@barwonhealth.org.au.
authors.forename: Michael
authors.initials: M
authors.lastname: Berk
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage*; D000339:Affect / Q000187:drug effects; D003863:Depression / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000523:psychology*; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D000111:Acetylcysteine